- Home
- GLP vs BEAM Comparison
GLP vs BEAM Comparison
Compare GLP & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLP
- BEAM
- Stock Information
- Founded
- GLP 2005
- BEAM 2017
- Country
- GLP United States
- BEAM United States
- Employees
- GLP N/A
- BEAM N/A
- Industry
- GLP Oil Refining/Marketing
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLP Energy
- BEAM Health Care
- Exchange
- GLP Nasdaq
- BEAM Nasdaq
- Market Cap
- GLP 1.8B
- BEAM 1.9B
- IPO Year
- GLP 2005
- BEAM 2020
- Fundamental
- Price
- GLP $52.57
- BEAM $23.44
- Analyst Decision
- GLP Strong Buy
- BEAM Buy
- Analyst Count
- GLP 1
- BEAM 10
- Target Price
- GLP $54.00
- BEAM $47.67
- AVG Volume (30 Days)
- GLP 73.7K
- BEAM 1.3M
- Earning Date
- GLP 02-26-2025
- BEAM 02-25-2025
- Dividend Yield
- GLP 5.52%
- BEAM N/A
- EPS Growth
- GLP N/A
- BEAM N/A
- EPS
- GLP 3.31
- BEAM N/A
- Revenue
- GLP $17,386,440,000.00
- BEAM $349,643,000.00
- Revenue This Year
- GLP $15.01
- BEAM N/A
- Revenue Next Year
- GLP $30.51
- BEAM $10.82
- P/E Ratio
- GLP $15.99
- BEAM N/A
- Revenue Growth
- GLP 5.31
- BEAM 328.73
- 52 Week Low
- GLP $37.00
- BEAM $20.84
- 52 Week High
- GLP $58.77
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- GLP 61.60
- BEAM 38.04
- Support Level
- GLP $48.80
- BEAM $22.50
- Resistance Level
- GLP $48.66
- BEAM $28.39
- Average True Range (ATR)
- GLP 2.09
- BEAM 1.68
- MACD
- GLP 0.72
- BEAM -0.41
- Stochastic Oscillator
- GLP 89.01
- BEAM 15.05
About GLP Global Partners LP Common Units representing Limited Partner Interests
Global Partners LP is an U.S.-based limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.